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1. IntroductIon
Exposure to adverse climatic conditions or stressors 
in organisms may cause pathological changes and beyond 
threshold stress limits, alterations in physiological functions 
appear. At high altitudes soldiers are exposed to adverse 
climatic conditions such as hypobaric hypoxia and suffer from 
symptoms of acute mountain sickness resulting in decreased 
physical and mental performance. A number of biologically 
active extracts derived from herbal plants growing at high 
altitudes have been reported to enhance stress tolerance and 
helps in faster adaptation in experimental animals1-2. However, 
in lack of specific drugs to alleviate high altitude pathologies, 
there is requirement for development of herbal agents to induce 
faster adaptation in high altitude conditions. 
Mushrooms have been part of the normal human diet 
and reported to be effective in promoting quality life and 
prevention of age related and life style disorders3-5. Many 
bio-active compounds of mushrooms such  as  gallic acid, 
caffeic  acid and its derivatives, quercetin, vanillin etc. can act 
as anti-oxidants6-8. Ganoderma lucidum (Fr.) Karst is one of 
such medicinal mushroom having distribution in tropical and 
temperate geographical regions9. In India, Ganoderma lucidum 
grows naturally at an altitude of over 4000 m of the North-West 
Himalayas at different locations of Uttarkhand, India. Further, 
in Southern parts of India, the presence of Ganoderma lucidum 
also has been recorded9. Ganoderma lucidum biosynthesizes 
phytochemicals including polysaccharides, adenosine, 
alkaloids, coumarin, ergosterols, ganoderic acids, lactones, 
mannitol, organic germanium, triterpenoids and rare minerals10-
11 that are linked to its numerous medicinal properties such as 
improving blood circulation, eliminates fatigue, strengthen 
immune system, enhance energy, discard toxins, anti-cancer 
property, effective in immunological disorders, heart disease 
and infection12-20. Our previous studies has demonstrated that 
aqueous extract of Ganoderma lucidum possess anti-stress, 
anti-inflammatory and endurance enhancing potential and 
further, prevent transvascular leakage in rat lung and has 
cardio-protective effects21-22. The findings from these provide 
rational for development of prophylactics/therapeutics agent 
based on aqueous extract of Ganoderma lucidum to offset 
high altitude maladies. However, drug stability is key issue 
that needs to be addressed in any drug development process 
and hence present investigations were carried out. The effect 
of storage temperature, if any, on qualitative and quantitative 
analysis of bio-constituent and efficacy of extract was studied 
up to two year. 
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ABSTRACT 
Stability testing is key requirement in the drug development process along with storage temperature which may 
deteriorate bio-constituents and efficacy of natural products. Aqueous extract of Ganoderma lucidum has revealed 
pharmacological effects against high altitude stressors and has potential for mitigating high altitude maladies. In the 
present study, the extract of Ganoderma lucidum was stored at different storage conditions such as room temperature, 
4 °C and -20 °C for two year and qualitative and quantitative analysis of bio-constituents and bio-efficacy was 
carried out. No significant change was observed in any extract kept in different temperature conditions in terms of 
its polysaccharide, phenolic and flavonoids content. The extract kept at room temperature absorbed slight moisture 
in few samples but no change in overall polysaccharide, phenolic and flavonoids content was recorded. The moisture 
absorption problem was not observed in extracts stored at 4 °C and -20 °C. The bio-efficacy of the extract at room 
temperature, 4 °C or -20 °C were comparable to the freshly prepared extract and the data from the studies suggest 
that extract has good shelf life up to two year without loss of bio-efficacy. Overall, the extract retained its bio-
efficacy for two years at different temperature storage conditions. 
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2. METhodS And MATERiAlS     2.3.4 Phenols
 The aqueous extract of Ganoderma lucidum 50 mg 
was dissolved in 5 ml distilled water and then 2-5 drops 
of neutral 5 per cent ferric chloride solution was added. 
The appearance of dark green coloration confirmed 
presence of phenol. 
 2.3.5 Flavonoids
A solution of aqueous extract of Ganoderma 
lucidum (2.5 %) was prepared in distilled water and 
then 2-5 drops of 10 N sodium hydroxide solution 
were added. Flavonoid presence can be detected with 
development of yellow colour. 
2.3.6 Glycosides
The aqueous extract of Ganoderma lucidum 5 ml (10 
mg/ml) was mixed with 5 ml of 25 per cent H2SO4 and was 
boiled in water bath for 15 mins. After 15 min of boiling, 5 
ml Fehling’s solution (5 ml) was added to this boiled mixture. 
Presence of steroidal ring of glycosides was confirmed with 
development of reddish brown colour.
2.3.7 Anthraquionones
The aqueous extract of Ganoderma lucidum 5 g was mixed 
with 5 ml benzene and shaken to properly dissolve the extract. 
After this 5 ml of 10 per cent ammonia solution was added to 
the mixture and shaken. Development of pink, red, or violet 
coloration in lower ammonical layer indicates the presence of 
free hydroxyl anthroquionones.
2.4 Quantitative Analysis 
Quantification of total polysaccharide, phenol, 
flavonoid and coumarin was carried out in extract of 
Ganoderma. 
 
2.4.1 Determination of Total Polysaccharides Content
The total polysaccharide content of aqueous extract was 
estimated using phenol-sulphuric acid method using D-glucose 
as standard as mentioned elsewhere24. Briefly, 1 ml of extract 
(10 mg/ml) solution was mixed with 1 ml of 5 per cent phenol 
solution and 5 ml of concentrated sulphuric acid and mixture 
was kept for 30 min with shaking and finally was read at 490 
nm and sugar content was measured using glucose standard 
curve. All experiments were repeated three time and data has 
been expressed in percentage. 
2.4.2 Determination of Total Phenol Content
The total phenolic content in extract was estimated using 
20 µl of stock solution (1 mg/ml) of the extract, 80 µl of water 
and 500 µl of Folin–Ciocalteu reagent as described elsewhere25. 
After 5 min incubation in the dark at room temperature, 400 
µl of 7.5 per cent sodium carbonate solution was added and 
mixture incubated for 30 min at room temperature (in dark) 
and finally absorbance was recorded at 765 nm. Total phenols 
(mg/g) in the extract were expressed as gallic acid equivalent 
(GAE), estimated from standard curve prepared from gallic 
acid (0.1 mg/ml) solution.
2.1  Collection of Plant Material
Reddish brown matured fruiting bodies of Ganoderma 
lucidum was collected from Pithoragarh, Uttrakhand, India 
(North-West Himalayas, ~ 4000 m altitude) from wood logs and 
tree stumps in rainy season. An Ethano-botanist, Dr. Mousin, 
Defence Institute of Bio Energy Research (DIBER), Haldwani, 
India characterised collected study material (voucher specimen 
DIP-GL/2014). The mature fruiting bodies of Ganoderma 
lucidum was washed with nanopure water and milled into 
powder after drying. 
2.2 Extraction Procedure
Aqueous extract of Ganoderma lucidum was prepared 
using Accelerated Solvent System ASE 350 equipped with a 
solvent controller unit (Dionex Corporation, CA, UsA). A 15 
min cycle was used for every extraction performed at room 
temperature. A rinse cycle was performed between extraction 
cycles to clear any previous extraction leftover. Finally, the 
supernatant solution was lyophilised (Allied frost, India) and 
the dried extract was stored at 4 ºC.
2.3 Qualitative Analysis
As described elsewhere23 phytochemical analysis was 
performed on extract of Ganoderma as follows: 
2.3.1 Steroids
2 ml acetic anhydride was added to 500 mg aqueous 
extract of Ganoderma lucidum and incubated on ice for 15 min 
and gradually sulphuric acid was added and color change was 
recorded. A change in colour to blue-green from violet shows 
presence of steroid in extract. 
2.3.2 Terpenoids
The aqueous extract of Ganoderma lucidum 0.5 g was 
added 2 ml chloroform and then sulphuric acid was later added 
to form a lower layer. The presence of terpenoids was confirmed 
by reddish- brown colour developed at the interface. 
2.3.3 Tannins
The aqueous extract of Ganoderma lucidum 5 g was 
stirred in 10 ml distilled water and filtered with whattman’s 
filter paper and then ferric chloride reagent was then added to 
this filtrate and formation of precipitate of blue-black or blue-
green color show presence of tannin. 
192
TUlsAwANI, et al.: DeF. lIFe sCI. J., VOl. 4, NO. 3, JUly 2019, DOI : 10.14429/DlsJ.4.13987
2.4.3 Determination of Total Flavonoid Content
Aluminium chloride method was used for estimation of 
total flavonoid content as described elsewhere26 using rutin as 
a standard. 1 ml extract was added to 4 ml distilled water and 
subsequently 0.3 ml of 5 per cent NaNO2 solution was added. 
After 5 min, 0.3 ml of 10 per cent AlCl3 solution was added 
and allowed to stand for 5 min, then 0.2 ml of 4 per cent NaOH 
solution was added to this mixture and finally distilled water 
was used to make volume to 10 ml and absorbance at 510 nm 
in spectrophotometer. The flavonoid content was expressed as 
mg/g of extract it terms of rutin equivalent. 
2.4.4  Determination of Coumarin
Coumarin was quantified in aqueous extract of Ganoderma 
lucidum using HPlC analysis (waters Corporation, UsA) 
equipped with Waters 515 HPLC pump, Waters 717 plus 
autosampler, and waters 2487 UV detector. separation was 
performed in a symmetry C18 250 mm × 4.7 mm ID, 5 𝜇m 
column (waters, UsA) by maintaining the isocratic flow rate 
(1 mL/min) of the mobile phase A. 0.01 M KH2PO4 pH 3.7 
and B. Methanol 90A:10B. 
2.5. Biological Assays 
The retention of bio-efficacy of extract was established 
using cell viability and reactive species levels in vitro. 
2.5.1 Mitochondrial Integrity MTT Assay
Cell viability was measured using MTT assay through 
reduction of mitochondrial enzyme succinate dehydrogenase 
as described elsewhere27. Briefly, MTT was dissolved in culture 
medium and filtered to remove a small amount of insoluble 
residue. Cell culture medium containing MTT at a concentration 
of 0.5 mg/ml was added to each well having adherent HT22 
cells in a total 200 µl medium and then incubated for 3 h. After 
incubation culture supernatant was aspirated and 100 µl of 
DMSO was added to dissolve formazan. Finally, absorbance 
was read at 570 nm following 30 min of incubation at room 
temperature (Power wave Xs2, BioTek, UsA).
2.5.2 Assay for Redox State
A fluorescent dye, H2-DCFH-DA was used to evaluate 
intracellular redox state. Briefly, cells medium was replaced 
with HBSS medium containing 5 µg of DCFH-DA and 
incubated at 37 °C for 30 min and fluorescence was recorded as 
485 nm excitation and 530 nm emission (Cary Eclipse, Varian, 
UsA).
2.5.3  Statistical analysis
The data obtained from the study is presented as mean 
± standard error. The data was subjected to one-way ANOVA 
with corrections for multiple comparisons using Dunnett’s test 
(Graph Pad Prism 2.01). statistical significance was estimated 
at the level of p < 0.05. 
3. RESulTS And diSCuSSionS
The products based on the extracts of Ganoderma 
lucidum are available widely as health care products28 and our 
Representative data of extract stored at room temperature for two years. 
similar findings were obtained for extract stored at 4 oC or -20 oC.
+ = fairly present; ++ = moderately present; +++ = strongly present














Anthraquinones Absent Absent Absent
Glycosides Present (+++) Present (+++) Present (+++)
Flavonoids Present (++) Present (++) Present (++)
Phenols Present (+++) Present (+++) Present (+++)
Polysaccharides Present (++) Present (++) Present (++)
Steroids Absent Absent Absent
Terpenoids Present (+) Present (+) Present (+)
Tannins Present (+) Present (+) Present (+)
previous studies provide rational for use of aqueous extract of 
Ganoderma lucidum as prophylactic or therapeutic agents for 
accelerating acclimatisation process at high altitude. In present 
study, stability of extract in terms of its bio-efficacy after its 
storage at different temperature has been addressed which has 
not been addressed previously. 
3.1  Qualitative Analysis: Phytochemical Screening of 
Aqueous Extract of Ganoderma lucidum
The physical characteristic of the extract was recorded. 
The freshly prepared extract had light brown color which did 
not change following two years of storage at cool conditions 
i.e. 4 oC or -20 oC. However, light brown colour changed to 
dark brown color in extract stored at room temperature due to 
absorption of moisture nevertheless the problem was noticed in 
few samples. The problem was resolved when the extract was 
stored at room temperature in gelatin capsules. 
The qualitative analysis of Ganoderma lucidum 
extract was carried out by estimating following metabolites: 
glycosides, flavonoids, phenols, polysaccharides, terpenoids, 
tannins and steroids. Orole23 extracted fruiting body of 
Ganoderma lucidum with two solvent system ethyl acetate 
and n-hexane and reported presence of phenol, flavonoid, 
saponins, terpenoids, glycosides and sterols. In another study, 
authors prepared aqueous and solvent extracts using ethyl 
acetate, chloroform, hexane and dichloromethane from two 
Ganoderma species from Tamil Nadu, Southern region of India 
and showed presence of saponins, terpenoids and tannins29. 
However, in all studies available on qualitative screening on 
Ganoderma lucidum extracts using water and solvents were 
conducted on freshly prepared extracts and no time dependent 
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analysis was conducted. In the present study, extract revealed 
presence of glycosides, flavonoids, phenols, polysaccharides, 
terpenoids and tannins but negative results for steroids and 
anthraquinones was recorded. The study was carried out over 
two year of storage and no qualitative change in extract was 





Figure 1.  Total polysaccharides (a), phenolic content (b), flavonoid 
content (c) and coumarin content (d) of aqueous extract 
of Ganoderma lucidum freshly prepared [Gl (FP), bar 
1] or stored at room temperature [Gl (RT)], 4 °C 
[Gl (4 °C] and -20 °C [Gl (-20 °C] for one year (1 
yr, bars 2, 4 and 6) and two years (2 yrs, bars 3, 5 
and 7), respectively. Mean values n =10 and data is 
expressed as percentage or mg/g extract. 
3.2 Quantitative Analysis: Studies on Effect of Storage 
Temperature on Aqueous Extract of Ganoderma 
lucidum using Chemical Test System
The aqueous extract was further subjected to quantitative 
analysis. It is reported that numerous pharmacological effects 
exhibited by Ganoderma are linked to its polysaccharide 
content and anti-oxidative activity30-32. Therefore, the content 
of polysaccharide, phenols and flavonoids were determined 
in aqueous extract of Ganoderma lucidum. In the present 
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study, no significant change was observed in any extract kept in 
different temperature conditions (ambient room temperature, 4 
oC and -20 oC) in terms of its phenolic and flavonoid up to two 
years of storage (Figs. 1(b) & (c)). The extract contains mixture 
of compounds and it is not possible to target all molecules 
hence coumarin which has been reported as active constituent 
in Ganoderma lucidum was determined in the extract. Further, 
major constituents in the Ganoderma lucidum are believed to 
be ganoderic acids however commercially these chemicals are 
not widely available. The extract content of coumarin which 
has been reported in Ganoderma lucidum also did not show 
any change in its content (Fig. 1(d)). 
3.3 Bio-efficacy study: Effect of Storage Conditions on 
Bio-Efficacy of Extract of Ganoderma lucidum
Numerous studies are available on pharmacological 
studies on aqueous extract of Ganoderma lucidum but still 
there is lack of reports on effects of different storage conditions 
and duration on bio-effects which is essential part for drug 
discovery particularly natural products. Therefore, effects of 
storage conditions and time dependent studies were carried 
out for the first time. The bio-efficacy of Ganoderma lucidum 
aqueous extract stored at ambient room temperature, 4 °C and 
-20 °C for two years was evaluated using HT22 cell model 
against hypoxia stress. Cells exposed to hypoxia (0.5 % O2) for 
24 h showed cell death and elevation of reactive species. The 
cells treated with extract prevented cell death and generation 
of reactive oxygen species (Figs. 2(a) & (b)). The storage 
temperature did not show any significant adverse impact on 
bio-efficacy of aqueous extract up to two years of storage. The 
aqueous extract of Ganoderma lucidum retained biological 
effects even after two years of storage at different temperature 
conditions i.e. ambient room temperature, 4 °C and -20 °C.
4.  ConCluSionS
The major inquest was to examine retention of bio-efficacy 
preferably in extract stored at room temperature or cooler 
conditions. In this study, no deterioration was observed in bio-
efficacy of extract in cells exposed to hypoxia even after storage 
at room temperature for two years. Overall, data obtained from 
the studies reveal that extract has good shelf life up to two years 
and extract stored at room temperature, 4 °C and -20 °C did not 
affect its bio-efficacy. Further, the extract is devoid of steroid 
content and hence suitable for the development of products for 
performance enhancement of soldiers at high altitude.   
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